Albert D Mason Inc Bristol Myers Squibb CO Transaction History

Albert D Mason Inc

$124 Million
Q4 2024

A detailed history of Albert D Mason Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Albert D Mason Inc holds 7,213 shares of BMY stock, worth $440,642. This represents 0.33% of its overall portfolio holdings.

Number of Shares

7,213

Previous 7,172 0.57%

Holding current value

$440,642

Previous $371,000 9.7%

% of portfolio

0.33%

Previous 0.29%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	BUY	$51.92 - $59.94 $2,128 - $2,457	41 Added 0.57%	7,213 $407,000
Q2 2024 Jul 16, 2024	SELL	$40.25 - $52.99 $1,408 - $1,854	-35 Reduced 0.49%	7,172 $297,000
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $24,805 - $28,124	517 Added 7.73%	7,207 $391,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $5,789 - $6,473	-100 Reduced 1.47%	6,690 $388,000
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $62,754 - $69,678	-985 Reduced 12.67%	6,790 $434,000
Q1 2023 Apr 11, 2023	SELL	$65.71 - $74.53 $20,370 - $23,104	-310 Reduced 3.83%	7,775 $539,000
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $9 - $5,378	70 Added 0.87%	8,085 $575,000
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $5,840 - $7,003	95 Added 1.2%	8,015 $585,000
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $138,365 - $161,301	2,580 Added 48.31%	7,920 $494,000
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $9,467 - $11,089	160 Added 3.09%	5,340 $316,000
Q2 2021 Jul 14, 2021	BUY	$61.91 - $67.42 $16,406 - $17,866	265 Added 5.39%	5,180 $346,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $16,318 - $18,353	275 Added 5.93%	4,915 $310,000
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $267,913 - $303,595	4,640 New	4,640 $288,000

Others Institutions Holding BMY

# of Institutions

2,761

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albert D Mason Inc, based on Form 13F filings with the SEC.

News

Stay updated on Albert D Mason Inc with notifications on news.

Account

Albert D Mason Inc Bristol Myers Squibb CO Transaction History